Bevacizumab for the treatment of neovascular age related macular degeneration.
Chakravarthy, Usha
Bevacizumab for the treatment of neovascular age related macular degeneration. [electronic resource] - BMJ (Clinical research ed.) Jun 2010 - c2834 p. digital
Publication Type: Comment; Editorial
1756-1833
10.1136/bmj.c2834 doi
Aged
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Bevacizumab
Humans
Macular Degeneration--drug therapy
Randomized Controlled Trials as Topic
Ranibizumab
Bevacizumab for the treatment of neovascular age related macular degeneration. [electronic resource] - BMJ (Clinical research ed.) Jun 2010 - c2834 p. digital
Publication Type: Comment; Editorial
1756-1833
10.1136/bmj.c2834 doi
Aged
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Bevacizumab
Humans
Macular Degeneration--drug therapy
Randomized Controlled Trials as Topic
Ranibizumab